作者:
Cleeland,C.S. [1]
;
Allen,J.D. [2]
;
Roberts,S.A. [3]
;
Brell,J.M. [4]
;
Giralt,S.A. [5]
;
Khakoo,A.Y. [6]
;
Kirch,R.A. [7]
;
Kwitkowski,V.E. [8]
;
Liao,Z. [9]
;
Skillings,J.
作者单位:
Quality of Life and Survivorship, American Cancer Society, Inc., 901 East Street NW #500
[1]
Research, Metabolic Disorders, Amgen, 1120 Veterans Boulevard, San Francisco, CA 94080, United
[2]
Office of Hematology Oncology Products, Center for Drug Evaluation and Research, FDA, 10903 New
[3]
Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, Box 235, 1275 York
[4]
Friends of Cancer Research, 2231 Crystal Drive, Arlington, VA 22202, United States
[5]
Department of Radiation Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe
[6]
Symptom Management and Drug Development, Community Oncology and Prevention Trials Research Group
[7]
Pfizer Medical Affairs, Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United States
[8]
Department of Symptom Research, University of Texas, MD Anderson Cancer Center, 1515 Holcombe
[9]
发布时间
2013-11-20